Skip to main content
. 2018 Apr 2;2(2):47–53. doi: 10.1002/jgh3.12045

Table 3.

Comparison of SIBO‐positive versus SIBO‐negative group

Parameters SIBO positive (n = 13) SIBO negative (n = 134) P‐value
Total, n (%) 13 (8.8) 134 (91.2) 0.018
Age, n (range) (years) 36 (25–43.5) 40.5 (33–50.25) 0.046
Diarrhea, n (%) 4 (30.8) 29 (21.6) 0.489
Abdominal discomfort, n (%) 12 (92.3) 109 (81.3) 0.466
Flatulence, n (%) 11 (84.6) 77 (57.5) 0.057
Abdominal bloating, n (%) 12 (92.3) 106 (79.1) 0.465
Abdominal distension, n (%) 8 (61.5) 56 (41.8) 0.170
Gender, n (%)
Male 8 (61.5) 66 (49.3) 0.398
Female 5 (38.5) 68 (50.7)
BMI (kg/m2) 25.33 ± 5.49 25.35 ± 4.65 0.987
Type of PPI, n (%)
Rabeprazole 8 (61.5) 84 (62.7) 1.000
Omeprazole 0 (0.0) 28 (20.9) 0.130
Pantoprazole 5 (38.5) 22 (16.4) 0.064
Duration of PPI (range) (months) 8 (6–24) 6 (4–18) 0.071
OCTT, n (range) (min) 160 (140–172.50) 120 (103.75–150.00) 0.002
OCTT, n (%)
Normal OCTT 0 (0.0) 37 (27.6) 0.039
Delayed OCTT 13 (100) 89 (70.6) 0.023
Fast OCTT 0 (0.0) 8 (6) 1.000

BMI, body mass index; OCTT, orocecal transit time; PPI, proton pump inhibitor; SIBO, small intestinal bacterial overgrowth.